Katherine MacLean, PhD. is the Director of the Psychedelic Education and Continuing Care Program and a trained research scientist with a long-standing interest in the brain and the science of well-being. At the University of California, Davis, Katherine was supported by a NSF research fellowship to study the effects of mindfulness on well-being and brain function. As a postdoctoral research fellow and faculty member at the Johns Hopkins University School of Medicine, she worked with Dr. Roland Griffiths and his team. Her research on psilocybin and personality change suggests that this class of medicines may play an important role in enhancing mental health, promoting emotional well-being, and creativity throughout the lifespan. Her current focus is the role of psychedelics and meditation in preparing individuals for end-of-life and healing trauma related to grief. Email: firstname.lastname@example.org
Dr. Ingmar Gorman is a clinical psychologist who specializes in assisting populations who have had experiences with psychedelics and other psychoactive compounds. He is the Administrative Director of the Psychedelic Education and Continuing Care Program, where he leads groups, trainings, and works with individual clients. Dr. Gorman is also site Co-principle Investigator and therapist on a Phase 3 clinical trial studying the potential psychotherapeutic utility of MDMA for post-traumatic stress disorder. He is a board member of Horizons Media, Inc., a not for-profit educational charity and organizer of the Horizons Conference: Perspectives on Psychedelics. Email: email@example.com
Andrew Tatarsky, Ph.D., is a leader in the field of harm reduction psychotherapy. The founder and director of The Center for Optimal Living in New York City, where treatment and professional training is based on Integrative Harm Reduction Therapy (IHRP). He has specialized in the field of substance use treatment for 30 years working as a counselor, psychologist, program director, trainer, advocate and author. He has devoted his career to developing a comprehensive understanding of the broad spectrum of substance use problems and an integrative harm reduction psychotherapy approach to treating this spectrum.
Jen Talley, Ph.D. is a clinical psychologist who specializes in the treatment of trauma and co-occurring substance misuse. Working from an integrative harm reduction framework, Dr. Talley’s approach is interactive and focuses on the development of practical skills to manage intense emotions, reduce self-judgment, and promote self-compassion. Mindfulness skills are integrated into an active exploration of the interrelationship between thoughts, feelings, physical sensations, and behaviors, along with their contribution to substance misuse and relationship issues. Dr. Talley is the Assistant Director of the Concentration in Mental Health and Substance Abuse Counseling at the New School for Social Research where she participates in the training and supervision of graduate students in psychology. Email: firstname.lastname@example.org